Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2016-01-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于注销用于补充流动资金相关募集资金专项账户的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 普莱柯生物工程股份有限公司 regarding the cancellation of a special account used for supplementary working capital raised through a previous public offering. It details the original fundraising, the opening of special accounts for the raised funds, and the recent closure of one such account. The document is short (1621 characters) and serves as a formal notice about the status of fundraising accounts rather than a financial report or detailed audit. It does not contain financial statements or detailed financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-01-07 Chinese
内部控制缺陷认定标准
Governance Information Classification · 95% confidence The document is a detailed internal control deficiency recognition standard issued by a company, describing classifications and criteria for internal control defects, both financial and non-financial. It includes definitions, qualitative and quantitative standards, and governance notes. It is a policy or governance document related to internal controls, not a financial report, audit report, or announcement. It does not contain financial statements or results, nor is it a certification or announcement of a report. It fits best under Governance Information (CGR) as it details internal control rules and standards established by the board for company operations and compliance.
2016-01-05 Chinese
内部控制评价管理办法
Governance Information Classification · 95% confidence The document is titled '内部控制评价管理办法' which translates to 'Internal Control Evaluation Management Measures'. It details the principles, content, procedures, defect recognition, and reporting related to the company's internal control evaluation process. It references regulatory guidelines such as the '企业内部控制基本规范' and Shanghai Stock Exchange internal control guidelines. The document is a management policy or procedural manual for internal control evaluation rather than an actual internal control evaluation report or audit report. It does not contain financial statements, audit opinions, or results of internal control audits but rather sets out the framework and methodology for conducting internal control evaluations. The document length is 4388 characters, which is relatively short and more consistent with a procedural or governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including internal control policies and procedures.
2016-01-05 Chinese
2015年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting of shareholders in 2015. It details the meeting date, attendance, voting results on a specific proposal, and legal verification by lawyers. There are no financial statements or detailed financial data presented. The document is an official announcement of the voting results from a shareholders' meeting, not the meeting materials or the full report itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, consistent with DVA filings.
2015-12-28 Chinese
2015年第三次临时股东大会的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality and procedures of a specific shareholders' meeting (the 2015 third extraordinary general meeting) of a company. It details the convening, attendance, voting procedures, and results of the meeting, confirming compliance with laws and company regulations. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of voting results but a legal opinion on the meeting's legality. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a legal compliance document related to a shareholders' meeting but not a direct voting result announcement or management report.
2015-12-28 Chinese
关于总经理增持公司股份暨维护公司股价稳定措施实施完成的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding increase by the company's general manager and related measures to stabilize the company's stock price. It details specific share purchases by company insiders, including dates, quantities, and prices, and references compliance with stock exchange rules and regulations. The document does not contain financial statements, earnings data, or detailed financial analysis. It is a disclosure about insider transactions and shareholding changes by directors and senior management. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this topic, confirming the classification.
2015-12-22 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.